Cargando…

Correction: Pancreatic Cancer: Feasibility and Outcome After Radiochemotherapy with High Dose External Radiotherapy for Non-resected and R1 Resected Patients

Detalles Bibliográficos
Autores principales:	Lauffer, David C, Kuhn, Peter A, Kueng, Marc, Thalmann, Sandrine U, Risse, Géraldine, Tercier, Pierre-Alain, Egger, Bernhard, Allal, Abdelkarim S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082580/ https://www.ncbi.nlm.nih.gov/pubmed/30105174 http://dx.doi.org/10.7759/cureus.c14

Ejemplares similares

Pancreatic Cancer: Feasibility and Outcome After Radiochemotherapy with High Dose External Radiotherapy for Non-resected and R1 Resected Patients
por: Lauffer, David C, et al.
Publicado: (2018)

Unusual Case of Laryngeal Squamous Cell Carcinoma with Cervical Metastasis of a Prostatic Adenocarcinoma: A Case Report
por: Lauffer, David Cédric, et al.
Publicado: (2017)

Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia
por: Jeromen, Ana, et al.
Publicado: (2012)

Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial
por: Versteijne, Eva, et al.
Publicado: (2016)

Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
por: Nichols, Romaine Charles, et al.
Publicado: (2019)

Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer
por: Duan, Ran, et al.
Publicado: (2021)

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2015)

Anastomotic Breakdown Five Years After Neoadjuvant Radiochemotherapy and Ultralow Anterior Resection for Rectal Adenocarcinoma
por: Nguyen, Eric, et al.
Publicado: (2020)

Feasibility of Comparing the Results of Pancreatic Resections between Surgeons: A Systematic Review and Meta-Analysis of Pancreatic Resections
por: Gurusamy, Kurinchi, et al.
Publicado: (2015)

A Retrospective Study on Radiotherapy and Radiochemotherapy in Esophageal Cancer
por: Kim, Chang-Min, et al.
Publicado: (1988)

Radiochemotherapy
Publicado: (1998)

Comparison of concurrent chemoradiotherapy versus sequential radiochemotherapy in patients with completely resected non-small cell lung cancer
por: Kim, Hwan-Ik, et al.
Publicado: (2016)

Meta-analysis of outcomes of patients with stage IV colorectal cancer managed with chemotherapy/radiochemotherapy with and without primary tumor resection
por: Lee, Ko-Chao, et al.
Publicado: (2016)

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy
por: Negri, F V, et al.
Publicado: (2008)

Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Janssen, Quisette P., et al.
Publicado: (2021)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
por: Janssen, Quisette P., et al.
Publicado: (2020)

Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
por: Massani, Marco, et al.
Publicado: (2023)

Lymph node retrieval in abdominoperineal surgical specimen is radiation time-dependent
por: Sermier, Alain, et al.
Publicado: (2006)

Salvage radiotherapy in patients with local recurrent esophageal cancer after radical radiochemotherapy
por: Zhou, Zhi-guo, et al.
Publicado: (2015)

Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy
por: Thureau, Sébastien, et al.
Publicado: (2021)

Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma
por: Habermehl, Daniel, et al.
Publicado: (2015)

Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer
por: Arscott, William T., et al.
Publicado: (2021)

Neoadjuvant chemotherapy and radiotherapy outcomes in borderline‐resectable and locally‐advanced pancreatic cancer patients
por: Botta, Gregory P., et al.
Publicado: (2022)

Feasibility of salvage endoscopic resection for patients with locoregional failure after definitive radiotherapy for pharyngeal cancer
por: Satake, Hironaga, et al.
Publicado: (2015)

Liver and Pancreatic Resection in the Elderly
por: Garden, O. J.
Publicado: (1997)

Palliative Resection of Pancreatic Adenocarcinoma
por: Johnson, C. D.
Publicado: (1995)

Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer
por: Kishi, Y., et al.
Publicado: (2019)

Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center
por: Ren, Lei, et al.
Publicado: (2023)

Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
por: Chiang, Kun-Chun, et al.
Publicado: (2012)

Impact of Pancreatic Resection on Survival in Locally Advanced Resectable Gastric Cancer
por: Chang, Shih-Chun, et al.
Publicado: (2021)

Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
por: Versteijne, Eva, et al.
Publicado: (2022)

Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer
por: Imamura, Masafumi, et al.
Publicado: (2021)

Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
por: Mikulic, Danko, et al.
Publicado: (2021)

Pancreatic Drainage Into the Stomach After Pancreatic Resection
por: Hermann, Robert E.
Publicado: (1991)

Comparison of the impact of radiotherapy and radiochemotherapy on the quality of life of 1-year survivors with cervical cancer
por: Krikeli, Marianthi, et al.
Publicado: (2011)

Dosimetric and motion analysis of margin-intensive therapy by stereotactic ablative radiotherapy for resectable pancreatic cancer
por: Heinzerling, John H, et al.
Publicado: (2011)

Hypofractionated Radiotherapy for Resectable Pancreatic Ductal Adenocarcinoma: A World First in Response to COVID19
por: Spiers, H.V., et al.
Publicado: (2022)

Combined Transarterial Chemoembolization and External Beam Radiotherapy in a Patient with Recurrent Huge Hepatocellular Carcinoma after Hepatic Resection
por: Yu, Jesang, et al.
Publicado: (2020)

Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor
por: Westgaard, Arne, et al.
Publicado: (2008)

Extended resection in pancreatic metastases: feasibility, frequency, and long-term outcome: a retrospective analysis
por: Wiltberger, Georg, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5pf55uqfk19n429p8nm35fsv64